Authors

IPD Serotypes Decreased Significantly During the COVID-19 Pandemic

After nearly 20 years of pneumococcal conjugate vaccine use in the Portuguese vaccine schedule, researchers explore serotype distribution in bacteria causing adult invasive pneumococcal disease (IPD).

Eloralintide Reduces Weight By 9.5% to 20.1% for Patients With Obesity

Eloralintide shows promising weight loss results in a phase 2 trial, offering a new option for obesity management with improved tolerability.

Pharmacists Provide Tailored Pneumococcal Vaccines to Patients With Down Syndrome

To optimize vaccine strategies among young people with Down syndrome, researchers explore the prevalence of adequate immune responses following pneumococcal vaccination.

Help Turn Occasional Shoppers into Loyal Customers by Investing in the Front End

Investing strategically in your pharmacy’s front end can enhance the customer experience and build lasting relationships

New Drug Review: FDA Approves Lazertinib Combination Therapy for Non–Small Cell Lung Cancer

Study results show improvement in progression-free survival at 22 months.

AI in Pharmacy: Transforming Workflows and Patient Care

Celebrating the Hard Work Pharmacists Do Everyday

Celebrate the vital role of pharmacists in health care this American Pharmacists Month.

The Future of Pharmacy: Where Technology Meets Trusted Care

Pharmacies are on the front lines of healthcare delivery, making it essential to empower pharmacy teams with the tools necessary to help manage their operations.

Healthy Margins: How Independent Pharmacies Can Strengthen Their Bottom Line

Independent pharmacists must not only prioritize patient care, but also financial stewardship, to maintain a confident business outlook amid industry headwinds.

FDA Approves Enflonsia for the Prevention of RSV Lower Respiratory Tract Disease in Infants

The approval expands options for protecting infants from respiratory syncytial virus, which remains a leading cause of pediatric hospitalization.

Your 2025 Pharmacy Legislation Update

Explore key legislative actions changing pharmacy practice in 2025 and beyond.

New Drug Review: Donanemab-azbt Approved for Early Symptomatic Alzheimer Disease

McKesson Amplify: A Turning Point for Pharmacy

In its inaugural year, McKesson Amplify has funded state pharmacy associations in all 50 states by empowering pharmacists and pharmacy teams with resources, advocacy, and training support

Beyond the Scale: The Pharmacist’s Role in Preserving Patients’ Muscle and Nutrition During GLP-1 Therapy

Pharmacists can help patients maintain muscle mass, meet their protein needs, and prevent nutritional deficiencies through evidence-based guidance that supports better overall health.

Q&A: Smarter Pharmacy Tools Are Making Patient Care Faster, Simpler | Asembia 2025

Sarah Thomas and David Skomo of HealthDyne discuss some of the most useful innovations that have been helpful for pharmacies.

Health Mart is ranked #1 in customer satisfaction among chain drug store pharmacies

Health Mart leads with innovative patient care, ranking #1 in Customer Satisfaction with Chain Drug Store Pharmacies in the J.D. Power 2025 U.S. Pharmacy Study℠.

The Pharmacist’s Ability to Overcome Barriers, Expand Contraceptive Services

As contraceptive care services remain fragmented across many US states, pharmacists are seemingly rising as key touch points for women’s health management and various types of reproductive care.